Agile Therapeutics to Participate in Upcoming Investor Conferences
September 07, 2021 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the...
Menotropin Market Sales are Expected to Grow at a CAGR of 5.5% through 2031
July 01, 2021 11:35 ET
|
insightSLICE
PUNE, India, July 01, 2021 (GLOBE NEWSWIRE) -- The Global Menotropin Market Share, Trends, Analysis and Forecasts, 2021-2031 provides insights on key developments, business strategies, research...
New Features in Exa Mammo Designed to Address Quality Assurance and Improve Communication
April 03, 2019 09:00 ET
|
Konica Minolta Healthcare Americas, Inc.
WAYNE, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., will highlight new features of Exa® Mammo, a PACS designed for breast imaging centers. Exa Mammo enables...
Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017
May 06, 2017 14:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., May 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced the presentation of additional results of its Phase 3 SECURE...
Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s Health
April 27, 2017 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company announced today that a presentation entitled “An Update on Hormonal...
Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months...
Agile Therapeutics Reports Third Quarter Financial Results
November 09, 2015 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
August 31, 2015 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Dr. Bruce Lee, Brings Expertise to Beverly Hills With New FDA Approved Acessa Fibroid Procedure
June 25, 2014 14:10 ET
|
Dr. Bruce Lee, M.D.
BEVERLY HILLS, CA--(Marketwired - Jun 25, 2014) - Dr. Bruce Lee, inventor of the Acessa procedure for treatment of uterine fibroids is pleased to announce that he has opened his practice at the Rox...